Risk perceptions of COVID-19 around the world S Dryhurst, CR Schneider, J Kerr, ALJ Freeman, G Recchia, ... COVID-19, 162-174, 2022 | 2110 | 2022 |
Susceptibility to misinformation about COVID-19 around the world J Roozenbeek, CR Schneider, S Dryhurst, J Kerr, ALJ Freeman, ... Royal Society open science 7 (10), 201199, 2020 | 1381 | 2020 |
Communicating uncertainty about facts, numbers and science AM Van Der Bles, S Van Der Linden, ALJ Freeman, J Mitchell, AB Galvao, ... Royal Society open science 6 (5), 181870, 2019 | 398 | 2019 |
The effects of communicating uncertainty on public trust in facts and numbers AM Van Der Bles, S van der Linden, ALJ Freeman, DJ Spiegelhalter Proceedings of the National Academy of Sciences 117 (14), 7672-7683, 2020 | 285 | 2020 |
COVID-19 risk perception: a longitudinal analysis of its predictors and associations with health protective behaviours in the United Kingdom CR Schneider, S Dryhurst, J Kerr, ALJ Freeman, G Recchia, ... Journal of Risk Research 24 (3-4), 294-313, 2021 | 228 | 2021 |
How accurate are accuracy-nudge interventions? A preregistered direct replication of Pennycook et al.(2020) J Roozenbeek, ALJ Freeman, S Van Der Linden Psychological science 32 (7), 1169-1178, 2021 | 151 | 2021 |
Effect of information about COVID-19 vaccine effectiveness and side effects on behavioural intentions: two online experiments JR Kerr, ALJ Freeman, TM Marteau, S van der Linden Vaccines 9 (4), 379, 2021 | 142 | 2021 |
Five rules for evidence communication M Blastland, ALJ Freeman, S van der Linden, TM Marteau, ... Nature 587 (7834), 362-364, 2020 | 141 | 2020 |
Correlates of intended COVID-19 vaccine acceptance across time and countries: results from a series of cross-sectional surveys JR Kerr, CR Schneider, G Recchia, S Dryhurst, U Sahlin, C Dufouil, ... BMJ open 11 (8), e048025, 2021 | 106 | 2021 |
How to communicate evidence to patients ALJ Freeman Drug and therapeutics bulletin 57 (8), 119-124, 2019 | 71 | 2019 |
Risk communication in tables versus text: a registered report randomized trial on ‘fact boxes' C Brick, M McDowell, ALJ Freeman Royal Society Open Science 7 (3), 190876, 2020 | 59 | 2020 |
How well did experts and laypeople forecast the size of the COVID-19 pandemic? G Recchia, ALJ Freeman, D Spiegelhalter PloS one 16 (5), e0250935, 2021 | 41 | 2021 |
Recommendations for designing genetic test reports to be understood by patients and non-specialists GD Farmer, H Gray, G Chandratillake, FL Raymond, ALJ Freeman European Journal of Human Genetics 28 (7), 885-895, 2020 | 40 | 2020 |
Winners and losers: communicating the potential impacts of policies C Brick, ALJ Freeman, S Wooding, WJ Skylark, TM Marteau, ... Palgrave Communications 4 (1), 1-13, 2018 | 38 | 2018 |
Predictors of COVID-19 vaccine acceptance across time and countries JR Kerr, CR Schneider, G Recchia, S Dryhurst, U Sahlin, C Dufouil, ... MedRxiv, 2020.12. 09.20246439, 2020 | 36 | 2020 |
First authentic capture of a coelacanth, Latimeria chalumnae (Pisces: Latimeriidae), off Madasgacar. PC Heemstra, ALJ Freeman South African journal of science 92 (3), 1996 | 36 | 1996 |
The adverse effects of bisphosphonates in breast cancer: A systematic review and network meta-analysis C Jackson, ALJ Freeman, Z Szlamka, DJ Spiegelhalter PloS one 16 (2), e0246441, 2021 | 32 | 2021 |
Teaching clinicians shared decision making and risk communication online: an evaluation study TC Hoffmann, C Del Mar, R Santhirapala, A Freeman BMJ evidence-based medicine 26 (5), 253-253, 2021 | 30 | 2021 |
Visualising SARS-CoV-2 transmission routes and mitigations H Rutter, S Parker, W Stahl-Timmins, C Noakes, A Smyth, R Macbeth, ... bmj 375, 2021 | 28 | 2021 |
Communicating personalized risks from COVID-19: guidelines from an empirical study ALJ Freeman, J Kerr, G Recchia, CR Schneider, ACE Lawrence, ... Royal Society open science 8 (4), 201721, 2021 | 28 | 2021 |